Literature DB >> 21792154

Ultrasound-accelerated thrombolysis for lower extremity ischemia: multicenter experience and literature review.

A Schrijver1, J Vos, A W Hoksbergen, B Fioole, W Fritschy, R Hulsebos, S De Jong, M M P Reijnen, J P P De Vries.   

Abstract

AIM: This study evaluates the short-term outcome of ultrasound-accelerated thrombolysis in patients with lower extremity ischemia caused by thromboembolic occlusions.
METHODS: A retrospective cohort study was conducted from December 2008 to May 2011 of 57 patients (42 men; median age, 66 ± 11 years) undergoing 62 episodes of ultrasound-accelerated thrombolysis for thromboembolic arterial occlusions of the lower extremities. The EKOS EndoWave System (EKOS Corporation, Bothell, WA, USA) was combined with urokinase (100000 IU/hour). Thirty-day and 6-month follow-up consisted of clinical evaluation, and Duplex scan or magnetic resonance angiography of the treated extremity.
RESULTS: Initial technical success was 97%, radiologic success was 82%, and overall clinical success was 77%. Median thrombolysis time was 21 hours (IQR, 15-24). In 38 of 51 procedures with successful lysis (75%) complete lysis was achieved within 24 hours. Major hemorrhage occurred in 2 procedures (3%), and distal embolization in 2 procedures (3%). During the initial hospitalization, the major amputation rate was 8% (N.=5) and the mortality rate was 2% (N.=1). The 30-day patency rate was 81%, without additional mortality. During a median 6-month (range, 2-14) follow-up, 9 reinterventions were performed. Two patients underwent major amputation and 3 patients died; because of malignancy (N.=2) and stroke (N.=1).
CONCLUSION: Initial success rates of ultrasound-accelerated thrombolysis are high and complication rate is low. However, reintervention rate during short-term follow-up for recurrent ischemia is substantial. Results from a randomized controlled trial comparing ultrasound-accelerated thrombolysis with standard thrombolysis for lower extremity ischemia (DUET, Current Controlled Trials, ISRCTN72676102) are eagerly awaited.

Entities:  

Mesh:

Year:  2011        PMID: 21792154

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  6 in total

Review 1.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

2.  Pulsed high-intensity-focused US and tissue plasminogen activator (TPA) versus TPA alone for thrombolysis of occluded bypass graft in swine.

Authors:  Nadine Abi-Jaoudeh; William F Pritchard; Hayet Amalou; Marius Linguraru; Oscar A Chiesa; Joshua D Adams; Carmen Gacchina; Robert Wesley; Subha Maruvada; Briana McDowell; Victor Frenkel; John W Karanian; Bradford J Wood
Journal:  J Vasc Interv Radiol       Date:  2012-05-19       Impact factor: 3.464

3.  Outcomes of lower extremity bypass performed for acute limb ischemia.

Authors:  Donald T Baril; Virendra I Patel; Dejah R Judelson; Philip P Goodney; James T McPhee; Nathanael D Hevelone; Jack L Cronenwett; Andres Schanzer
Journal:  J Vasc Surg       Date:  2013-05-25       Impact factor: 4.268

4.  Successful reversal of acute kidney failure by ultrasound-accelerated thrombolysis of an occluded renal artery.

Authors:  Renske Konings; Rutger J Lely; Shaikh A Nurmohamed; Arjan W J Hoksbergen
Journal:  Case Rep Med       Date:  2014-09-08

Review 5.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

6.  Maintaining Patency of Vascular Access for Haemodialysis.

Authors:  Nicholas Inston; J Al Shakarchi; A Khawaja; R Jones
Journal:  Cardiovasc Eng Technol       Date:  2017-07-18       Impact factor: 2.495

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.